8 Results for "

nik+inhibitors

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "nik+inhibitors" in MCE Product Catalog:

19
19 Publications Verification
Cat. No.: HY-120501
CAS No.: 1202764-53-1
Purity:  99.37%
Target:  

NF-κB

Research Areas:  

Inflammation/Immunology

B022 is a potent and selective NF-κB-inducing kinase (NIK) inhibitor (Ki of 4.2 nM; IC50=15.1 nM). B022 protects liver from toxin-induced inflammation, oxidative stress, and injury . B022 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-112433
CAS No.: 1660114-31-7
Purity:  99.95%
Target:  

NF-κB

Research Areas:  

Inflammation/Immunology

NIK SMI1 is a potent, selective NF-κB inducing kinase (NIK) inhibitor, which inhibits NIK-catalyzed hydrolysis of ATP to ADP with IC50 of 0.23±0.17 nM. NIK SMI1 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-112433A
CAS No.: 2984765-48-0
Purity:  99.28%
Target:  

NF-κB Drug Isomer

Research Areas:  

Inflammation/Immunology

(S)-NIK SMI1 is the isomer of NIK SMI1 (HY-112433), and can be used as an experimental control. NIK SMI1 is a potent, selective NF-κB inducing kinase (NIK) inhibitor, which inhibits NIK-catalyzed hydrolysis of ATP to ADP with IC50 of 0.23±0.17 nM.
loading...
    loading...
Cat. No.: HY-122007
CAS No.: 1202764-63-3
Target:  

NF-κB

Research Areas:  

Cancer

AM-0561 is a NIK inhibitor (Ki: 0.3 nM). AM-0561 decreases p52 levels .
loading...
    loading...
Cat. No.: HY-149696
CAS No.: 2387927-74-2
IR-Crizotinib is a NF-κB-inducing kinase (NIK) inhibitor that crosses the blood-brain barrier and fluorescently localizes intracranial glioblastoma (GBM) in mice (IC50=3.381 μM). IR-Crizotinib is conjugated from the near-infrared dye IR-786 and the NF-κB-inducing kinase (NIK) inhibitor Crizotinib. IR-Crizotinib can effectively inhibit the growth and invasion of glioma in vitro and in vivo and can be used in cancer research .
loading...
    loading...
Cat. No.: HY-163478
CAS No.: 3038178-73-0
Target:  

NF-κB

Research Areas:  

Inflammation/Immunology

TNIK-IN-9 (Compound 54) is a selective and potent NIK inhibitor, with an IC50 of 1.27 nM. TNIK-IN-9 can inhibit pro-inflammatory cytokines and nitric oxide production. TNIK-IN-9 exhibits significant anti-inflammatory effects, improved mortality, and hepatoprotective effects in sepsis models .
loading...
    loading...
Cat. No.: HY-117222
CAS No.: 1202764-61-1
Target:  

NF-κB

Research Areas:  

Inflammation/Immunology Cancer

AM-0216 is a highly selective NF-κB-inducing kinase (NIK) inhibitor with a Ki value of 2 nM. AM-0216 is promising for research of NF-κB-dependent hematologic malignancies (e.g., multiple myeloma) and autoimmune diseases .
loading...
    loading...
Cat. No.: HY-179701
NIK-IN-3 is a potent and orally active NF-κB-inducing kinase (NIK) inhibitor with an IC50 of 5.2 nM. NIK-IN-3 suppresses non-canonical NF-κB pathway activation and inhibits the secretion of pro-inflammatory cytokines, such as TNF-α, IL-6, IL-1β and chemokine CXCL12. NIK-IN-3 shows significant anti-inflammatory effects in LPS (HY-D1056)-induced sepsis mice model and DSS (HY-116282)-induced colitis model. NIK-IN-3 can be used for the research of inflammation, such as colitis .
loading...
    loading...